CN100345583C - 治疗气阴两虚型月经过多症的中药制剂及其制法和应用 - Google Patents
治疗气阴两虚型月经过多症的中药制剂及其制法和应用 Download PDFInfo
- Publication number
- CN100345583C CN100345583C CNB2005100126640A CN200510012664A CN100345583C CN 100345583 C CN100345583 C CN 100345583C CN B2005100126640 A CNB2005100126640 A CN B2005100126640A CN 200510012664 A CN200510012664 A CN 200510012664A CN 100345583 C CN100345583 C CN 100345583C
- Authority
- CN
- China
- Prior art keywords
- radix
- deficiency
- preparation
- fine powder
- clear paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000007106 menorrhagia Diseases 0.000 title claims abstract description 29
- 230000007812 deficiency Effects 0.000 title claims description 28
- 238000000034 method Methods 0.000 title claims description 8
- 208000022168 hypermenorrhea Diseases 0.000 title 1
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 51
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 51
- 238000002360 preparation method Methods 0.000 claims abstract description 47
- 239000003814 drug Substances 0.000 claims abstract description 46
- 239000000843 powder Substances 0.000 claims description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 41
- 239000012567 medical material Substances 0.000 claims description 41
- 108010052008 colla corii asini Proteins 0.000 claims description 39
- 241000756943 Codonopsis Species 0.000 claims description 38
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 30
- 239000007788 liquid Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000000284 extract Substances 0.000 claims description 23
- 238000010411 cooking Methods 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 20
- 239000002775 capsule Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 235000019640 taste Nutrition 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000000469 ethanolic extract Substances 0.000 claims description 4
- 239000011812 mixed powder Substances 0.000 claims description 2
- 238000012360 testing method Methods 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 108010010803 Gelatin Proteins 0.000 abstract description 3
- 229920000159 gelatin Polymers 0.000 abstract description 3
- 239000008273 gelatin Substances 0.000 abstract description 3
- 235000019322 gelatine Nutrition 0.000 abstract description 3
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 abstract description 2
- 230000037396 body weight Effects 0.000 abstract description 2
- 231100000132 chronic toxicity testing Toxicity 0.000 abstract description 2
- 230000034994 death Effects 0.000 abstract description 2
- 230000002496 gastric effect Effects 0.000 abstract description 2
- 231100001252 long-term toxicity Toxicity 0.000 abstract description 2
- 231100000915 pathological change Toxicity 0.000 abstract description 2
- 230000036285 pathological change Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 235000016993 Agrimonia Nutrition 0.000 abstract 1
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 241001446509 Psoralea Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 241000238371 Sepiidae Species 0.000 abstract 1
- 208000031971 Yin Deficiency Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 244000144980 herd Species 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 18
- 230000000694 effects Effects 0.000 description 9
- 230000023597 hemostasis Effects 0.000 description 9
- -1 reflux Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 210000004914 menses Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000001502 supplementing effect Effects 0.000 description 6
- 238000012856 packing Methods 0.000 description 5
- 208000037920 primary disease Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010000210 abortion Diseases 0.000 description 3
- 231100000176 abortion Toxicity 0.000 description 3
- 229960002949 fluorouracil Drugs 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000002439 hemostatic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010004272 Benign hydatidiform mole Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000022555 Genital disease Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000006937 Hydatidiform mole Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001567 anti-fibrinolytic effect Effects 0.000 description 1
- 229940082620 antifibrinolytics Drugs 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000007116 gestational trophoblastic neoplasm Diseases 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100126640A CN100345583C (zh) | 2005-07-08 | 2005-07-08 | 治疗气阴两虚型月经过多症的中药制剂及其制法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100126640A CN100345583C (zh) | 2005-07-08 | 2005-07-08 | 治疗气阴两虚型月经过多症的中药制剂及其制法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1723980A CN1723980A (zh) | 2006-01-25 |
CN100345583C true CN100345583C (zh) | 2007-10-31 |
Family
ID=35923697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100126640A Active CN100345583C (zh) | 2005-07-08 | 2005-07-08 | 治疗气阴两虚型月经过多症的中药制剂及其制法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100345583C (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071582A (zh) * | 1991-10-12 | 1993-05-05 | 龙孟麟 | 再生障碍性贫血转化为白血病 |
CN1480522A (zh) * | 2003-08-06 | 2004-03-10 | 蔡玉堂 | 一种药酒组合物及其制备方法 |
-
2005
- 2005-07-08 CN CNB2005100126640A patent/CN100345583C/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071582A (zh) * | 1991-10-12 | 1993-05-05 | 龙孟麟 | 再生障碍性贫血转化为白血病 |
CN1480522A (zh) * | 2003-08-06 | 2004-03-10 | 蔡玉堂 | 一种药酒组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1723980A (zh) | 2006-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1310654C (zh) | 一种治疗妇科疾病的药物及其制备方法 | |
CN1785367A (zh) | 一种治疗崩漏、呕血及便血的药物 | |
CN1765392A (zh) | 一种补血调经,止血安胎的中药复方制剂及其制备方法 | |
CN1726991A (zh) | 治疗妇女痛经、月经不调、产后虚弱的药物及其制备方法 | |
CN101214315B (zh) | 一种预防和治疗妇科出血的药物及其制备方法 | |
CN1785292A (zh) | 一种治疗崩漏的药物及其制备方法 | |
CN101224290B (zh) | 治疗肝郁痰凝型乳癖的中药及其制备方法 | |
CN1150041A (zh) | 一种治疗胆肾结石的中成药 | |
CN100345583C (zh) | 治疗气阴两虚型月经过多症的中药制剂及其制法和应用 | |
CN1055227C (zh) | 一种治疗男性不育症的药物及制备方法 | |
CN116115702A (zh) | 一种加味蜂房丸组合物及其应用 | |
CN1291751C (zh) | 治疗乳腺小叶增生的药物及其制备工艺 | |
CN102343019B (zh) | 一种用于治疗闭经的中药组合物及其制剂的制备方法 | |
CN101259214B (zh) | 一种治疗乳腺增生的药物 | |
CN102058851A (zh) | 一种治疗乳癖、乳核的药物 | |
CN100342888C (zh) | 一种治疗前列腺增生的中药制剂及其制备方法和应用 | |
CN103251883A (zh) | 一种抗肿瘤药物组合物及其制备方法 | |
CN1191849C (zh) | 一种治疗乳癖的中药 | |
CN102397326A (zh) | 一种当归益母汤的配方与制作 | |
CN105343147A (zh) | 一种治疗产后乳汁分泌不足的中药包及其制备方法和应用 | |
CN1456198A (zh) | 安宫止血药物 | |
CN104800768B (zh) | 一种治疗产后缺乳的中药组合物 | |
CN1814113A (zh) | 一种治疗乳腺增生的药物组合物及其制备工艺 | |
CN101954046A (zh) | 一种治疗乳腺增生的药物 | |
CN1298371C (zh) | 一种治疗乳腺增生病的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: RONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD. Free format text: FORMER NAME: SHANDONG LUTAI HUANZHONG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 255086, No. 17, Yan Yan Avenue, Zibo hi tech Development Zone, Shandong, China Patentee after: RONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD. Address before: 255086, No. 17, Yan Yan Avenue, Zibo hi tech Development Zone, Shandong, China Patentee before: Lutai Huanzhong Pharmaceutical Co., Ltd., Shandong |
|
ASS | Succession or assignment of patent right |
Owner name: YANGTZE RIVER PHARMACEUTICAL GROUP GUANGZHOU HAIRU Free format text: FORMER OWNER: RONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD. Effective date: 20111019 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 255086 ZIBO, SHANDONG PROVINCE TO: 510000 GUANGZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20111019 Address after: 510000 No. 31 Xiangshan Road, Guangzhou science and Technology Development Zone, Guangzhou hi tech Development Zone, Guangdong Patentee after: Yangzijiang Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co.,Ltd. Address before: 255086, No. 17, Yan Yan Avenue, Zibo hi tech Development Zone, Shandong, China Patentee before: RONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180716 Address after: 255086 17 Lanyan Avenue, Zibo new hi tech Industrial Development Zone, Shandong Patentee after: RONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD. Address before: 510000 Guangzhou high tech Development Zone, Guangdong, 31 Xiangshan Road, Guangzhou Science City. Patentee before: Yangzijiang Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right |